Emergent BioSolutions (EBS) News Today → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free EBS Stock Alerts $5.55 +0.28 (+5.31%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16, 2024 | investorplace.comVice Stock Vanguards: 3 Sin Stocks Delivering Heavenly ReturnsMay 10, 2024 | globenewswire.comEmergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024May 2, 2024 | msn.comEmergent BioSolutions gains as results top estimates, co to cut 300 jobsMay 2, 2024 | msn.comEmergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?May 2, 2024 | bizjournals.comWhy this Gaithersburg biotech's stock is surgingMay 2, 2024 | finance.yahoo.comQ1 2024 Emergent BioSolutions Inc Earnings CallMay 2, 2024 | investorplace.comEmergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job CutsMay 2, 2024 | finance.yahoo.comEmergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...May 2, 2024 | investorplace.comWhy Is Emergent BioSolutions (EBS) Stock Up 57% Today?May 2, 2024 | investorplace.comEBS Stock Earnings: Emergent BioSolutions Beats EPS, Beats Revenue for Q1 2024May 1, 2024 | bizjournals.comGaithersburg biotech to shutter Baltimore facility amid cost-cuttingMay 1, 2024 | bizjournals.comEmergent BioSolutions eliminating 300 jobs, shutting down multiple facilitiesMay 1, 2024 | finance.yahoo.comNarcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close FacilitiesMay 1, 2024 | finance.yahoo.comEmergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...May 1, 2024 | globenewswire.comEmergent BioSolutions Reports First Quarter 2024 Financial ResultsMay 1, 2024 | reuters.comEmergent BioSolutions to lay off about 300 employeesMay 1, 2024 | globenewswire.comEmergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial PositionMay 1, 2024 | marketbeat.comTraders Buy Large Volume of Put Options on Emergent BioSolutions (NYSE:EBS)Emergent BioSolutions Inc. (NYSE:EBS - Get Free Report) was the recipient of unusually large options trading on Wednesday. Traders acquired 3,153 put options on the stock. This represents an increase of 344% compared to the typical volume of 710 put options.May 1, 2024 | globenewswire.comEmergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to NaloxoneMay 1, 2024 | markets.businessinsider.comEmergent BioSolutions earnings: here's what Wall Street expectsApril 30, 2024 | bizjournals.comEmergent BioSolutions doling out big bonuses to retain top execsApril 30, 2024 | globenewswire.comEmergent BioSolutions Announces Amendment to its Existing Credit FacilityApril 24, 2024 | msn.comFDA approves Amneal's generic version of OTC NarcanApril 24, 2024 | marketbeat.comEmergent BioSolutions (EBS) to Release Earnings on WednesdayEmergent BioSolutions (NYSE:EBS) will be releasing earnings after the market closes on Wednesday, May 1, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=587152)April 22, 2024 | globenewswire.comEmergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024April 17, 2024 | finance.yahoo.comInstitutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year lossesApril 14, 2024 | marketbeat.comShort Interest in Emergent BioSolutions Inc. (NYSE:EBS) Expands By 16.1%Emergent BioSolutions Inc. (NYSE:EBS - Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,700,000 shares, a growth of 16.1% from the March 15th total of 4,910,000 shares. Based on an average daily volume of 2,980,000 shares, the days-to-cover ratio is currently 1.9 days. Currently, 11.4% of the shares of the stock are short sold.April 11, 2024 | marketbeat.comEmergent BioSolutions' (EBS) Buy Rating Reiterated at BenchmarkBenchmark reiterated a "buy" rating and set a $5.00 price target on shares of Emergent BioSolutions in a report on Thursday.April 5, 2024 | marketbeat.comAssenagon Asset Management S.A. Acquires 651,480 Shares of Emergent BioSolutions Inc. (NYSE:EBS)Assenagon Asset Management S.A. lifted its holdings in shares of Emergent BioSolutions Inc. (NYSE:EBS - Free Report) by 356.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 834,372 shares of the biopharmaceutical company's stockApril 1, 2024 | finance.yahoo.comAquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveMarch 30, 2024 | marketbeat.comEmergent BioSolutions Inc. (NYSE:EBS) Short Interest Down 20.8% in MarchEmergent BioSolutions Inc. (NYSE:EBS - Get Free Report) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 4,910,000 shares, a decrease of 20.8% from the February 29th total of 6,200,000 shares. Based on an average daily volume of 3,000,000 shares, the short-interest ratio is presently 1.6 days. Approximately 9.8% of the shares of the company are sold short.March 28, 2024 | globenewswire.comEmergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid CrisisMarch 27, 2024 | bizjournals.comWhy this Maryland biotech furloughed 130 workers in MichiganMarch 25, 2024 | globenewswire.comEmergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing FacilityMarch 12, 2024 | marketwatch.comEmergent BioSolutions Shares Drop on S&P DowngradeMarch 7, 2024 | realmoney.thestreet.comBenchmark gets more bullish on Emergent BioSolutions, upgrades sharesMarch 7, 2024 | realmoney.thestreet.comEmergent BioSolutions upgraded to Buy at Benchmark after 'upbeat' Q4 reportMarch 7, 2024 | finance.yahoo.comEmergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial ResultsMarch 7, 2024 | finance.yahoo.comEmergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | marketbeat.comEmergent BioSolutions (NYSE:EBS) Lifted to Buy at BenchmarkBenchmark upgraded shares of Emergent BioSolutions from a "hold" rating to a "buy" rating and set a $5.00 target price on the stock in a report on Thursday.March 7, 2024 | finance.yahoo.comQ4 2023 Emergent BioSolutions Inc Earnings CallMarch 7, 2024 | fool.comEmergent BioSolutions (EBS) Q4 2023 Earnings Call TranscriptMarch 6, 2024 | investorplace.comEBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023March 6, 2024 | benzinga.comEmergent BioSolutions: Q4 Earnings InsightsMarch 6, 2024 | globenewswire.comEmergent BioSolutions Reports Fourth Quarter 2023 Financial ResultsMarch 6, 2024 | globenewswire.comEmergent BioSolutions Reports Fourth Quarter 2023 Financial ResultsMarch 6, 2024 | msn.comEmergent Biosolutions Q4 2023 Earnings PreviewMarch 6, 2024 | marketbeat.comEmergent BioSolutions (NYSE:EBS) Posts Earnings Results, Beats Expectations By $0.14 EPSEmergent BioSolutions (NYSE:EBS - Get Free Report) issued its earnings results on Wednesday. The biopharmaceutical company reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.14. Emergent BioSolutions had a negative return on equity of 28.54% and a negative net margin of 72.06%. During the same period last year, the business posted ($0.31) earnings per share.March 5, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Has $5.31 Million Stock Holdings in Emergent BioSolutions Inc. (NYSE:EBS)Charles Schwab Investment Management Inc. boosted its stake in Emergent BioSolutions Inc. (NYSE:EBS - Free Report) by 44.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,561,050 sharesMarch 4, 2024 | benzinga.comEmergent BioSolutions's Earnings: A Preview Get Emergent BioSolutions News Delivered to You Automatically Sign up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter. Email Address Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. EBS Media Mentions By Week EBS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EBS News Sentiment▼-0.030.42▲Average Medical News Sentiment EBS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EBS Articles This Week▼12▲EBS Articles Average Week Get Emergent BioSolutions News Delivered to You Automatically Sign up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: XOMA News VNDA News MACK News VSTM News RIGL News RGLS News LXRX News OPK News INVA News IRWD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EBS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emergent BioSolutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
